A STUDY OF HEMOSTASIS IN ISCHEMIC CEREBROVASCULAR-DISEASE .2. ABNORMALITIES IN PLATELET ADP RELEASE, PLATELET CYCLOOXYGENASE REGENERATION TIME AND PLATELET FACTOR-III AVAILABILITY

被引：8
|
作者：
METTINGER, KL [1 ]
EGBERG, N [1 ]
机构：
[1] KAROLINSKA INST,KAROLINSKA HOSP,DEPT BLOOD COAGULAT DISORDERS,S-10401 STOCKHOLM 60,SWEDEN
来源：
THROMBOSIS RESEARCH | 1982年 / 26卷 / 03期
关键词：
D O I：
10.1016/0049-3848(82)90140-2
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：193 / 201
页数：9
相关论文
共 13 条
  • [1] RELEASE AND AVAILABILITY OF PLATELET FACTOR-III UNDER CERTAIN CONDITIONS
    MOHAMMAD, SF
    SHARMA, NC
    CHUANG, HYK
    MASON, RG
    FEDERATION PROCEEDINGS, 1981, 40 (03) : 810 - 810
  • [2] SHORTENED MEGAKARYOCYTE-PLATELET REGENERATION TIME IN PATIENTS WITH ISCHEMIC CEREBROVASCULAR-DISEASE
    HAMBERG, M
    SVENSSON, J
    BLOMBACK, M
    METTINGER, KL
    THROMBOSIS RESEARCH, 1981, 21 (06) : 675 - 679
  • [3] SPONTANEOUS PLATELET-AGGREGATION IN CEREBROVASCULAR-DISEASE .2. FURTHER CHARACTERIZATION OF THE PLATELET DEFECT
    HOOGENDIJK, EMG
    JENKINS, CSP
    VANWIJK, EM
    VOS, J
    CATE, JWT
    THROMBOSIS AND HAEMOSTASIS, 1979, 41 (03) : 512 - 522
  • [4] CITATION-CLASSIC - THE KAOLIN CLOTTING TIME OF PLATELET-RICH PLASMA - A TEST OF PLATELET FACTOR-III AVAILABILITY
    HARDISTY, RM
    CURRENT CONTENTS/LIFE SCIENCES, 1986, (12): : 16 - 16
  • [5] THE EFFECT OF CARBAMOYLPIPERIDINE AND NIPECOTOYLPIPERAZINE ANALOGS ON ADP-STIMULATED HUMAN THROMBOCYTE AGGREGATION AND PLATELET FACTOR-III AVAILABILITY
    DILLINGHAM, EO
    LASSLO, A
    GOLLAMUDI, R
    BOND, SE
    CARTERBURKS, G
    RESEARCH COMMUNICATIONS IN CHEMICAL PATHOLOGY AND PHARMACOLOGY, 1990, 67 (02): : 179 - 199
  • [6] RISTOCETIN INDUCED PLATELET FACTOR-III AVAILABILITY, A POSSIBLE NEW TOOL IN THE DIAGNOSIS OF VONWILLEBRANDS DISEASE
    MUSZBEK, L
    LOSONCZY, H
    HARSFALVI, J
    NAGY, I
    THROMBOSIS AND HAEMOSTASIS, 1981, 46 (01) : 333 - 333
  • [7] A STUDY OF HEMOSTASIS IN ISCHEMIC CEREBROVASCULAR-DISEASE .1. ABNORMALITIES IN FACTOR-VIII AND ANTITHROMBIN
    METTINGER, KL
    THROMBOSIS RESEARCH, 1982, 26 (03) : 183 - 192
  • [8] ACTIVITY OF PLATELET-ACTIVATING FACTOR (PAF) ACETYLHYDROLASE IN PLASMA FROM PATIENTS WITH ISCHEMIC CEREBROVASCULAR-DISEASE
    SATOH, K
    IMAIZUMI, T
    KAWAMURA, Y
    YOSHIDA, H
    TAKAMATSU, S
    MIZONO, S
    SHOJI, B
    TAKAMATSU, M
    PROSTAGLANDINS, 1988, 35 (05): : 685 - 698
  • [9] RISTOCETIN-INDUCED PLATELET FACTOR-III AVAILABILITY, A POSSIBLE NEW TOOL IN THE DIAGNOSIS OF VONWILLEBRANDS DISEASE
    MUSZBEK, L
    LOSONCZY, H
    HARSFALVI, J
    NAGY, I
    JOURNAL OF CLINICAL CHEMISTRY AND CLINICAL BIOCHEMISTRY, 1981, 19 (08): : 780 - 780
  • [10] DECREASED PLATELET-AGGREGATION, CA-2+ AND MG-2+ ATPASE AND PLATELET FACTOR-III ACTIVITIES IN PATIENTS WITH WILSON DISEASE
    COHEN, AM
    BRETTBART, H
    CRETER, D
    LEVINSKY, H
    FRYDMAN, M
    DJALDETTI, M
    HAEMATOLOGICA, 1984, 69 (03) : 263 - 271
12